Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab.
JCO Clin Cancer Inform
; 8: e2300220, 2024 Aug.
Article
en En
| MEDLINE
| ID: mdl-39088775
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Carcinoma Hepatocelular
/
Anticuerpos Monoclonales Humanizados
/
Bevacizumab
/
Neoplasias Hepáticas
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
JCO Clin Cancer Inform
Año:
2024
Tipo del documento:
Article